Biodefense Market Witnessing an Admirable Growth Due to the Disease Surveillance Mission

Biodefense is a measure to combat the potential effects of bioterrorism that utilizes biological agents, or deploys biological weaponry. Bioterrorism is a deliberate release of biological agents such as bacteria, virus, germs or toxins which may be in natural or human modified form, in order to make them more virulent, or to enhance their potential to cause infection, or to make them drug resistant. These biological agents can be transmittedthrough water, air, food or from person to person.Biodefense is usually utilized in two ways, either as a defense against an attack on a military target or civil population. Defense against an attack on acivilian is largely based on the detection and methods by which casualties and loss of water or food can be minimized. Biodefense against an attack on military targets is concerned with preparing military personnelready to respond to bioterrorism.

Download Complete Healthcare Analytical Brochure:
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=5369

The global biodefense market is witnessing an admirable growth due to the disease surveillance mission which has become increasingly important with the fear of bioterrorism. After the attack of September 11, 2001 came the subsequent outbreak of anthrax, spores of which were mailed through the U.S. postal system. These events brought into notice that all levels of government need to focus on improving public health preparedness and to improve the response time for the next disaster. Bioterrorism preparedness funding has enabled the Public Health Services to significantly enhance the reach of its surveillance activities, thus more effectively monitor the community’s health. After the incidence, the focus was shifted to the development of tests and procedures to detect and identify bio threat agents. Recent outbreak in the form of Ebola and nuclear crisis in Japan are expected to significantly drive the growth of the biodefense market.

Research Report: http://www.transparencymarketresearch.com/biodefense-market.html

In terms of geography, North America followed by Europe accounted for the largest share of biodefense market due to enhanced lab capabilities, and improved activity for implementing rapid health alert system. Asia Pacific is expected to be a prospective biodefense market due to the rising adoption rate of precise analytical instruments and highly developing biotechnology industry. Moreover, other regions such as the Middle East and Latin America are expected to be the potential market in the near future due to expansion of major biotechnology players in these regions.

Some of the major players in biodefense market are Alnylam Pharmaceuticals, Acambis plc, Dynavax Technologies, Inc, Evogen, Inc., Emergent BioSolutions, Human Genome Sciences, SIGA Technologies, and PharmAthene, Inc.

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.